Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised controlled trial in systemic cancer treatment

Overview of attention for article published in BMC Cancer, May 2017

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
High Attention Score compared to outputs of the same age and source (83rd percentile)

Mentioned by

twitter: 8 X users

Readers on

mendeley: 234 Mendeley

Summary X

So far, Altmetric has seen 9 X posts from 8 X users, with an upper bound of 17,463 followers.

THE RCT: https://t.co/NzUln6RkEn •Single centre 2 arm RCT: usual care vs usual care +eRAPID •N= 508 patients starting chemotherapy for breast, gynae or colorectal cancer •Over 18 weeks from start of treatment •Weekly completion of eRAPID online symptom rep

01 Jun 2020

Reply Repost Favourite

Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): a randomised con... https://t.co/RLPhuBVxWo

25 May 2017

Reply Repost Favourite

Brand new #openaccess article just added to our Repository: https://t.co/AEZllt2ldy https://t.co/nbEoq7jUEi

18 May 2017

Reply Repost Favourite

RT @DrKateAbsolom: Great to see our @POGWeb protocol for the eRAPID systemic RCT is now in press https://t.co/NzUln6RkEn

18 May 2017

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.